Guidelines for the Prevention of Stroke in Women A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association

被引:640
作者
Bushnell, Cheryl
McCullough, Louise D.
Awad, Issam A.
Chireau, Monique V.
Fedder, Wende N.
Furie, Karen L.
Howard, Virginia J.
Lichtman, Judith H.
Lisabeth, Lynda D.
Pina, Ileana L.
Reeves, Mathew J.
Rexrode, Kathryn M.
Saposnik, Gustavo
Singh, Vineeta
Towfighi, Amytis
Vaccarino, Viola
Walters, Matthew R.
机构
关键词
AHA Scientific Statements; atrial fibrillation; hormone replacement therapy; menopause; metabolic syndrome X; preeclampsia; eclampsia; sex differences; stroke; BODY-MASS INDEX; POSTMENOPAUSAL HORMONE-THERAPY; CARDIOVASCULAR-DISEASE RISK; CEREBRAL VENOUS THROMBOSIS; ESTROGEN PLUS PROGESTIN; LIFE-STYLE INTERVENTION; PROSPECTIVELY-DESIGNED OVERVIEWS; TRANSIENT ISCHEMIC ATTACK; DURAL SINUS THROMBOSIS; LONG-TERM OUTCOMES;
D O I
10.1161/01.str.0000442009.06663.48
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Purpose The aim of this statement is to summarize data on stroke risk factors that are unique to and more common in women than men and to expand on the data provided in prior stroke guidelines and cardiovascular prevention guidelines for women. This guideline focuses on the risk factors unique to women, such as reproductive factors, and those that are more common in women, including migraine with aura, obesity, metabolic syndrome, and atrial fibrillation. Methods Writing group members were nominated by the committee chair on the basis of their previous work in relevant topic areas and were approved by the American Heart Association (AHA) Stroke Council's Scientific Statement Oversight Committee and the AHA's Manuscript Oversight Committee. The panel reviewed relevant articles on adults using computerized searches of the medical literature through May 15, 2013. The evidence is organized within the context of the AHA framework and is classified according to the joint AHA/American College of Cardiology and supplementary AHA Stroke Council methods of classifying the level of certainty and the class and level of evidence. The document underwent extensive AHA internal peer review, Stroke Council Leadership review, and Scientific Statements Oversight Committee review before consideration and approval by the AHA Science Advisory and Coordinating Committee. Results We provide current evidence, research gaps, and recommendations on risk of stroke related to preeclampsia, oral contraceptives, menopause, and hormone replacement, as well as those risk factors more common in women, such as obesity/metabolic syndrome, atrial fibrillation, and migraine with aura. Conclusions To more accurately reflect the risk of stroke in women across the lifespan, as well as the clear gaps in current risk scores, we believe a female-specific stroke risk score is warranted.
引用
收藏
页码:1545 / 1588
页数:44
相关论文
共 449 条
[21]   Sex differences in US mortality rates for stroke and stroke subtypes by race/ethnicity and age, 1995-1998 [J].
Ayala, CN ;
Croft, JB ;
Greenlund, KJ ;
Keenan, NL ;
Donehoo, RS ;
Malarcher, AM ;
Mensah, GA .
STROKE, 2002, 33 (05) :1197-1201
[22]   Premature menopause is associated with increased risk of cerebral infarction in Japanese women [J].
Baba, Yosuke ;
Ishikawa, Shizukiyo ;
Amagi, Yoko ;
Kayaba, Kazunori ;
Gotoh, Tadao ;
Kajii, Eiji .
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2010, 17 (03) :506-510
[23]   Association between the current use of low-dose oral contraceptives and cardiovascular arterial disease: A meta-analysis [J].
Baillargeon, JP ;
McClish, DK ;
Essah, PA ;
Nestler, JE .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (07) :3863-3870
[24]  
Bakhai A, 2008, QJM-INT J MED, V101, P767, DOI 10.1093/qjmed/hcn066
[25]   Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis [J].
Barnett, HJM ;
Taylor, W ;
Eliasziw, M ;
Fox, AJ ;
Ferguson, GG ;
Haynes, RB ;
Rankin, RN ;
Clagett, GP ;
Hachinski, VC ;
Sackett, DL ;
Thorpe, KE ;
Meldrum, HE ;
Spence, JD .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (20) :1415-1425
[26]   Patient recognition of and response to symptoms of TIA or stroke [J].
Barr, J ;
McKinley, S ;
O'Brien, E ;
Herkes, G .
NEUROEPIDEMIOLOGY, 2006, 26 (03) :168-175
[27]   ACE INHIBITOR FETOPATHY AND HYPOCALVARIA - THE KIDNEY SKULL CONNECTION [J].
BARR, M ;
COHEN, MM .
TERATOLOGY, 1991, 44 (05) :485-495
[28]   Raloxifene and cardiovascular events in osteoporotic postmenopausal women - Four-year results from the MORE (Multiple Outcomes of Raloxifene Evaluation) randomized trial [J].
Barrett-Connor, E ;
Grady, D ;
Sashegyi, A ;
Anderson, PW ;
Cox, DA ;
Hoszowski, K ;
Rautaharju, P ;
Harper, KD .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (07) :847-857
[29]   Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women [J].
Barrett-Connor, Elizabeth ;
Mosca, Lori ;
Collins, Peter ;
Geiger, Mary Jane ;
Grady, Deborah ;
Kornitzer, Marcel ;
McNabb, Michelle A. ;
Wenger, Nanette K. .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (02) :125-137
[30]   Intracerebral hemorrhage in pregnancy - Frequency, risk factors, and outcome [J].
Bateman, B. T. ;
Schumacher, H. C. ;
Bushnell, C. D. ;
Pile-Spellman, J. ;
Simpson, L. L. ;
Sacco, R. L. ;
Berman, M. F. .
NEUROLOGY, 2006, 67 (03) :424-429